160 related articles for article (PubMed ID: 38466821)
1. Letter to the Editor: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
Muñoz AE; Rodger EG
Hepatology; 2024 Jul; 80(1):E8. PubMed ID: 38466821
[No Abstract] [Full Text] [Related]
2. Reply: Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
Sharpton S; Loomba R
Hepatology; 2024 Jul; 80(1):E9-E10. PubMed ID: 38466795
[No Abstract] [Full Text] [Related]
3. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects.
Vargas JI; Arrese M; Shah VH; Arab JP
Curr Gastroenterol Rep; 2017 Sep; 19(9):43. PubMed ID: 28752475
[TBL] [Abstract][Full Text] [Related]
4. Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC.
Sharpton SR; Loomba R
Hepatology; 2023 Dec; 78(6):1896-1906. PubMed ID: 37013380
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of statins in the diseases of the liver.
Janicko M; Drazilova S; Pella D; Fedacko J; Jarcuska P
World J Gastroenterol; 2016 Jul; 22(27):6201-13. PubMed ID: 27468210
[TBL] [Abstract][Full Text] [Related]
6. [The application of non-selective β-blockers, angiotensin receptor antagonists and statins in liver cirrhotic patients].
Zhang XX; Guo JS
Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):923-928. PubMed ID: 31941254
[TBL] [Abstract][Full Text] [Related]
7. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor: Statin Reduces the Risk of Hepatocellular Carcinoma Development in Patients With CHB.
Zhang BH; Cai YS; Song JL; Lyu T; Yang J; Jiang L; Yang JY
Hepatology; 2021 Apr; 73(4):1621-1622. PubMed ID: 32965687
[No Abstract] [Full Text] [Related]
9. Comprehensive evaluation of effects and safety of statin on the progression of liver cirrhosis: a systematic review and meta-analysis.
Gu Y; Yang X; Liang H; Li D
BMC Gastroenterol; 2019 Dec; 19(1):231. PubMed ID: 31888534
[TBL] [Abstract][Full Text] [Related]
10. Effects of statins and aspirin on HCC risk in alcohol-related cirrhosis: nationwide emulated trials.
Kraglund F; Christensen DH; Eiset AH; Villadsen GE; West J; Jepsen P
Hepatol Commun; 2023 Jan; 7(1):e0013. PubMed ID: 36633465
[TBL] [Abstract][Full Text] [Related]
11. Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
Pinyopornpanish K; Al-Yaman W; Butler RS; Carey W; McCullough A; Romero-Marrero C
Am J Gastroenterol; 2021 Nov; 116(11):2258-2269. PubMed ID: 34212895
[TBL] [Abstract][Full Text] [Related]
12. Targeting the gut-liver axis in cirrhosis: antibiotics and non-selective β-blockers.
Madsen BS; Havelund T; Krag A
Adv Ther; 2013 Jul; 30(7):659-70. PubMed ID: 23881723
[TBL] [Abstract][Full Text] [Related]
13. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
[TBL] [Abstract][Full Text] [Related]
14. Letter: sorafenib in portal hypertension.
Procopet B; Bureau C; Peron JM
Aliment Pharmacol Ther; 2012 Nov; 36(10):994; author reply 994-5. PubMed ID: 23072608
[No Abstract] [Full Text] [Related]
15. Cirrhosis as new indication for statins.
Bosch J; Gracia-Sancho J; Abraldes JG
Gut; 2020 May; 69(5):953-962. PubMed ID: 32139553
[TBL] [Abstract][Full Text] [Related]
16. Potential for statins in the chemoprevention and management of hepatocellular carcinoma.
Lonardo A; Loria P
J Gastroenterol Hepatol; 2012 Nov; 27(11):1654-64. PubMed ID: 22849701
[TBL] [Abstract][Full Text] [Related]
17. Simvastatin Prevents Progression of Acute on Chronic Liver Failure in Rats With Cirrhosis and Portal Hypertension.
Tripathi DM; Vilaseca M; Lafoz E; Garcia-Calderó H; Viegas Haute G; Fernández-Iglesias A; Rodrigues de Oliveira J; García-Pagán JC; Bosch J; Gracia-Sancho J
Gastroenterology; 2018 Nov; 155(5):1564-1577. PubMed ID: 30055171
[TBL] [Abstract][Full Text] [Related]
18. Current and future pharmacological therapies for managing cirrhosis and its complications.
Kockerling D; Nathwani R; Forlano R; Manousou P; Mullish BH; Dhar A
World J Gastroenterol; 2019 Feb; 25(8):888-908. PubMed ID: 30833797
[TBL] [Abstract][Full Text] [Related]
19. Statins and the risks of decompensated liver cirrhosis and hepatocellular carcinoma determined in patients with alcohol use disorder.
Chiu WC; Shan JC; Yang YH; Chen VC; Chen PC
Drug Alcohol Depend; 2021 Nov; 228():109096. PubMed ID: 34600254
[TBL] [Abstract][Full Text] [Related]
20. Statin and aspirin for prevention of hepatocellular carcinoma: what are the levels of evidence?
Carrat F
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):9-11. PubMed ID: 24183917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
